Vivakor
VIVK
#11243
Rank
โ‚ฌ1.08 M
Marketcap
0,21ย โ‚ฌ
Share price
-6.08%
Change (1 day)
90.70%
Change (1 year)

P/E ratio for Vivakor (VIVK)

P/E ratio as of November 2026 (TTM): 0.0000

According to Vivakor's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -4.11399E-6. At the end of 2025 the company had a P/E ratio of 0.0000.

P/E ratio history for Vivakor from 2009 to 2026

PE ratio at the end of each year

Year P/E ratio Change
20250.0000-99.68%
20240.0000-15.67%
20230.0000167.56%
20220.0000-95.24%
2021-0.0003-68.67%
2020-0.0010
2009-0.0013

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Merrimack Pharmaceuticals
MACK
-138 3,343,347,842.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-19.7 479,337,477.39%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-17.9 434,057,834.03%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.